ICD-10-CM Code for Diffuse large B-cell lymphoma C83.3

ICD-10 code C83.3 for Diffuse large B-cell lymphoma is a medical classification as listed by WHO under the range - Malignant neoplasms .

Official Long Descriptor

Diffuse large B-cell lymphoma

Anaplastic diffuse large B-cell lymphoma
CD30-positive diffuse large B-cell lymphoma
Centroblastic diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma, subtype not specified
Immunoblastic diffuse large B-cell lymphoma
Plasmablastic diffuse large B-cell lymphoma
Diffuse large B-cell lymphoma, subtype not specified
T-cell rich diffuse large B-cell lymphoma

Excludes1: mediastinal (thymic) large B-cell lymphoma (C85.2-)
mature T/NK-cell lymphomas (C84.-)

C83

Excludes1: personal history of non-Hodgkin lymphoma (Z85.72)

Additional/Related Information

Tabs

Get crucial instructions for accurate ICD-10-CM C83.3 coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.

This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code.

Crosswalks

Tabs

ICD-9-CM CROSSWALK

Forum

Have a question about ICD-10-CM Code C83.3 ? Start a discussion here

Need lymphoma expert!

I am hoping for a lymphoma expert.... Dictation: Patient was diagnosed with a follicular lymphoma in the summer 2021. He subsequently underwent palliative chemotherapy with Bendamustine and Rituxan... [ Read More ]

Triple Hit Lymphoma...

[QUOTE="emonet01, post: 502157, member: 136057"] To my knowledge, there is not specific for "Triple Hit" specifically. You would code to the type of Lymphoma. I see Double Hit Diffuse Large B-Cell Lym... [ Read More ]

Triple Hit Lymphoma...

[QUOTE="Whidbey, post: 502147, member: 430025"] Hello, High grade B-cell lymphoma with a finding of Burkitt lymphoma related clone detected. The Provider selected Diffuse ultimately as there is not a... [ Read More ]

Post Procedural Sepis

I am looking for some clarification . If this would be coded correctly post procedure sepsis T80.212A port infection[IMG]https://tpc.googlesyndication.com/simgad/7687950239744743933[/IMG] A49.1 sepsi... [ Read More ]

Coding sepsis

I'm looking for clarity on coding sepsis post procedure. This is how I think is should be coded. T80.212A port infection A41.9 sepsis unspecified R65.21 severe sepsis N17.9 acute kidney failure C83.10... [ Read More ]

Coding for Recurrent Lymphoma

:confused: I work for a Hematology/Oncology practice. The patient was said to have Stage IV indolent low grade B-cell lymphoma with associated splenic and bone marrow involvement (due to progressive... [ Read More ]

Assistance with IR coding scenarios

I'm new to interventional radiology and need some assistance with the following coding scenarios that I've been working with at home for practice. The following 5 cases have be stumped, any assistance... [ Read More ]

Marginal Zone Lymphoma

I am trying to determine the best codes for the different types of MZL. C88.4 is obvious for MALT, but would C83.0X be appropriate for nodal and splenic? Any help with diagnosis codes for all MZL (nod... [ Read More ]

Dlbcl

I can see the confusion here. Adrenal glands are effector organs, not solid organs by definition, meaning C83.39 would be inaccurate, however they are extranodal, meaning C83.39 could be accurate. I'd... [ Read More ]

Dlbcl

[QUOTE="ancoleman22, post: 394457, member: 289650"]I have a chart here that has been coded twice with two different codes and it has me questioning which code is correct! It states DLBCL of the righ... [ Read More ]

View All

Coding Alert(s)

Tabs

Related Articles
CMS Center

See links to CMS documents related to your ICD-10-CM code without changing pages or searching the Web. Create your account here for Free Trial to Codify's CMS Center!

Latest News

CAR-T Reimbursement Requirements Revamped Again

Learn the latest changes to reporting products and procedures related to Chimeric Antigen Receptor Tcell therapy to ensure proper coding. Expensive cuttingedge cancer therapy is available to Medicare ... [ Read More ]

CAR-T Coding Update

C9076 is the newest addition to the list of HCPCS Level II codes for CART therapies effective July 1. Learn the latest changes to reporting products and procedures related to Chimeric Antigen Receptor... [ Read More ]

View All News